Wellnex Life (ASX:WNX) is set to launch a one-for-one non-renounceable entitlement offer to raise up to AU$22.1 million, in parallel with the Company's proposed listing on the London Stock Exchange, according to a Monday Australian bourse filing.
The entitlement offer is not underwritten and it is on the same terms as the capital raise in the UK for the proposed dual listing on AIM, a submarket of the London bourse.
The offer will open on Feb. 17, the filing said.
It priced the capital raise in conjunction with the proposed dual listing at AU$0.65 per share, in consultation with lead brokers, SP Angel, Orana Capital, and Barclay Pearce Capital, and following feedback from UK institutions.
It plans to use the proceeds to redeem the convertible notes, pay the outstanding deferred consideration for pain away, and fund general working capital, including the cost of the offer and the proposed listing.
The firm began a marketing campaign for its proposed dual listing, the filing said.
The firm's shares fell past 16% on market close on Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.